Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla®): a review of its use in the management of HIV infection.
about
In vitro analysis and quantitative prediction of efavirenz inhibition of eight cytochrome P450 (CYP) enzymes: major effects on CYPs 2B6, 2C8, 2C9 and 2C19Vitamin D deficiency aggravates nephrotoxicity, hypertension and dyslipidemia caused by tenofovir: role of oxidative stress and renin-angiotensin system.Single-Tablet Regimens in HIV TherapyNephrotoxicity of HAARTThe impact of neurobehavioral features on medication adherence in HIV: evidence from longitudinal modelsAntiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz.Comparative manufacture and cell-based delivery of antiretroviral nanoformulations.Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents.Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates.Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment RegimensSingle Tablet Regimen Usage and Efficacy in the Treatment of HIV Infection in AustraliaCharacterization of peripheral and mucosal immune responses in rhesus macaques on long-term tenofovir and emtricitabine combination antiretroviral therapy.Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild®): a review of its use in the management of HIV-1 infection in adults.Drug-Drug Interactions Among Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Medications.Effect of co-administration of Hypoxis hemerocallidea extract and antiretroviral therapy (HAART) on the histomorphology and seminal parameters in Sprague Dawley rats.Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management.Rare emergence of drug resistance in HIV-1 treatment-naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe.Testicular histomorphologic and stereological alterations following short-term treatment with highly active antiretroviral drugs (HAART) in an experimental animal model.Direct monthly highly active antiretroviral therapy supply - a method to increase patient's adherence and outcome. Experience of one AIDS centre in Israel.Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats.[Efficacy and tolerability of antiretroviral therapy containing tenofovir disoproxil fumarate-emtricitabine-efavirenz in treatment-naive patients infected with HIV-1 in Bobo Dioulasso (Burkina Faso, 2009-2011)].
P2860
Q33821729-E479F3A6-946E-4386-963E-12ECDC648CC5Q33928535-1694802D-7363-4FB1-9F61-80204B221A94Q33939110-E682A696-F8AA-41F4-95E2-81A62B0FA46FQ35167944-39A5D828-07A1-4B71-978B-F486E524B0FEQ35533693-7E38435E-91F3-4BD1-8DA4-4DF55356E23EQ35547048-E8A1B8C3-C40E-47B4-AF7B-5B4ADB8CBEBAQ35677168-6DEE64E5-6E31-4336-BF5D-09BB8133890CQ35751916-CB34F842-592F-4D1A-8B8F-319A402382BDQ36188725-8F8DB691-8B84-4893-9FE1-8AE87E1EE8EEQ36206941-746B04DB-4AE6-4455-86D5-62DAAA7A43B7Q36208913-A70F948C-5E03-4B33-AE84-24E473F77BB0Q36389032-E0DE5E41-7F0A-4EF3-8114-BFD6BBB26D05Q38009758-33B742E1-ACF1-4171-81B8-8F695CF8A46BQ38171345-8CBBD581-2596-4B0A-A494-07C721720574Q38432073-4EBFBD3F-ADD0-49ED-BFCC-333E9DF20EB5Q38853889-162A9DDB-77E4-4F8D-9B6A-29FDD4C56D40Q40188381-F0481BFF-4C1E-4DBC-93B6-1181AC0FB3BFQ40785692-15E968FB-0A2E-4AB7-B651-EC2A63FD895EQ41293200-2D1C90E2-D2D0-4B80-8B69-9EDDFF8F2C6FQ42213076-2C6BCB14-86F3-4AC9-AABD-0A7208DA75A9Q42248267-722AB82B-7CA5-4AB8-B90B-B3E98974C8A7Q43475720-A08FD284-C3A0-4F41-A108-70C03C52049CQ43928195-4EDF39FB-3B65-42E3-9FDF-7A9CED1DB814
P2860
Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla®): a review of its use in the management of HIV infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efavirenz/emtricitabine/tenofo ...... e management of HIV infection.
@en
Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen
@nl
type
label
Efavirenz/emtricitabine/tenofo ...... e management of HIV infection.
@en
Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen
@nl
prefLabel
Efavirenz/emtricitabine/tenofo ...... e management of HIV infection.
@en
Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen
@nl
P1433
P1476
Efavirenz/emtricitabine/tenofo ...... e management of HIV infection.
@en
P2093
Emma D Deeks
P304
P356
10.2165/11203800-000000000-00000
P577
2010-12-01T00:00:00Z
P6179
1040028405